CMS Should Clarify Coverage For Device Trials, Manufacturers Say
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers are asking for a clearer path to Medicare coverage of their clinical studies
You may also be interested in...
CMS Advisory Committee Supports Humanitarian-Device Trial Coverage
A Medicare advisory panel voted overwhelmingly Dec. 13 to allow coverage of all humanitarian-use devices in studies that fall under the agency's revised clinical research policy
CMS Advisory Committee Supports Humanitarian-Device Trial Coverage
A Medicare advisory panel voted overwhelmingly Dec. 13 to allow coverage of all humanitarian-use devices in studies that fall under the agency's revised clinical research policy
Advisory Committee To Discuss Changes To CMS’ Trial Payment Policy
CMS will seek guidance from the Medicare Coverage Advisory Committee (MCAC) Dec. 13 on revising its policy for reimbursing certain device clinical trial costs